# Study of A3309 in Patients With Dyslipidemia

> **NCT01069783** · PHASE2 · COMPLETED · sponsor: **Albireo** · enrollment: 36 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** A3309
- **DRUG:** A3309
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01069783
- **Lead sponsor:** Albireo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01069783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01069783, "Study of A3309 in Patients With Dyslipidemia". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01069783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*